DK0512916T3 - Liposomale prostaglandinformuleringer - Google Patents

Liposomale prostaglandinformuleringer

Info

Publication number
DK0512916T3
DK0512916T3 DK92401262T DK92401262T DK0512916T3 DK 0512916 T3 DK0512916 T3 DK 0512916T3 DK 92401262 T DK92401262 T DK 92401262T DK 92401262 T DK92401262 T DK 92401262T DK 0512916 T3 DK0512916 T3 DK 0512916T3
Authority
DK
Denmark
Prior art keywords
prostaglandin
cell activation
adhesion
syndrome
prostaglandin formulations
Prior art date
Application number
DK92401262T
Other languages
English (en)
Inventor
Marc J Ostro
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of DK0512916T3 publication Critical patent/DK0512916T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92401262T 1991-05-07 1992-05-06 Liposomale prostaglandinformuleringer DK0512916T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69731491A 1991-05-07 1991-05-07
US87620092A 1992-04-30 1992-04-30

Publications (1)

Publication Number Publication Date
DK0512916T3 true DK0512916T3 (da) 1999-09-20

Family

ID=27105991

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92401262T DK0512916T3 (da) 1991-05-07 1992-05-06 Liposomale prostaglandinformuleringer

Country Status (15)

Country Link
EP (1) EP0512916B1 (da)
JP (1) JPH06507417A (da)
KR (1) KR100300772B1 (da)
AT (1) ATE176401T1 (da)
AU (1) AU664704B2 (da)
CA (1) CA2108788C (da)
DE (1) DE69228332T2 (da)
DK (1) DK0512916T3 (da)
ES (1) ES2128343T3 (da)
FI (1) FI934913A (da)
GR (1) GR3029641T3 (da)
IE (1) IE921461A1 (da)
MX (1) MX9202131A (da)
NO (1) NO306048B1 (da)
WO (1) WO1992019243A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5811118A (en) * 1987-05-22 1998-09-22 The Liposome Company, Inc. Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
US5882678A (en) * 1990-01-12 1999-03-16 The Liposome Co, Inc. Interdigitation-fusion liposomes containing arachidonic acid metabolites
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
CA2175057A1 (en) * 1993-11-04 1995-05-11 Robert P. Lenk Multilamellar liposomal arachidonic acid metabolite formulations
ATE176397T1 (de) * 1993-11-16 1999-02-15 Liposome Co Inc Arachidonsäuremetaboliten enthaltende interdigitations-fusions-liposomen
JPH10507737A (ja) * 1994-01-11 1998-07-28 ザ リポソーム カンパニー、インコーポレーテッド アラキドン酸代謝産物および粒子製剤を用いる治療
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US6001333A (en) * 1997-09-12 1999-12-14 See; Jackie R. Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
WO2008018932A2 (en) 2006-05-01 2008-02-14 The Board Of Trustees Of The Leland Stanford Junior University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
AU617678B2 (en) * 1987-05-22 1991-12-05 Liposome Company, Inc., The Prostaglandin-lipid formulations

Also Published As

Publication number Publication date
IE921461A1 (en) 1992-11-18
WO1992019243A1 (en) 1992-11-12
NO306048B1 (no) 1999-09-13
NO934016D0 (no) 1993-11-05
EP0512916B1 (en) 1999-02-03
EP0512916A3 (en) 1992-12-09
CA2108788A1 (en) 1992-11-12
EP0512916A2 (en) 1992-11-11
CA2108788C (en) 2003-09-30
MX9202131A (es) 1993-04-01
AU664704B2 (en) 1995-11-30
GR3029641T3 (en) 1999-06-30
AU2027392A (en) 1992-12-21
JPH06507417A (ja) 1994-08-25
FI934913A0 (fi) 1993-11-05
NO934016L (no) 1993-11-05
DE69228332D1 (de) 1999-03-18
KR100300772B1 (ko) 2001-10-22
FI934913A (fi) 1993-11-05
DE69228332T2 (de) 1999-09-16
ES2128343T3 (es) 1999-05-16
ATE176401T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
ATE176401T1 (de) Liposomale prostaglandinformulierungen
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI891389A (fi) Menetelmä makeutusaineen valmistamiseksi
DE58906076D1 (de) Benzophenonderivate und deren Herstellung.
FI880815A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 5-okso-4,5-dihydro-imidatso/1,5-a/kinatsoliinijohdannaisten valmistamiseksi
DE3577722D1 (de) Derivat des adult-t-zell-leukemiavirus-antigenpeptids.
FI892684A0 (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI891004A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi
FI102066B1 (fi) Menetelmä farmakologisesti aktiivisen 2,5,6,7-tetranor-4,8-inter-m-fenyleeni-PGI2-johdannaisen valmistamiseksi sekä välituote
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI873750A (fi) Anordning foer detektering av en begynnande uppvisningsansats i ett ark under framstaellning av arket.
FI83875B (fi) Ett nytt foerfarande foer framstaellning av 4-deoxipyrido/1'2':1,2/imidazo/5,4-c/rifamyciner.
FI89047C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-tioner
GB2207574B (en) High gain amplifier using two current mirrors
FI91526B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi
NO177673C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N7-substituerte mitomycinderivater
FI893121A (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
FI931891A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 7,8-dihydroksi-1H-imidatso- ja pyratsolo/3,4-f/kinoksaliinijohdannaisten valmistamiseksi
FI96855B (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
FI912247A (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrrolo/2,3-b/indoliketonijohdannaisten valmistamiseksi
IT208707Z2 (it) Veicolo motorizzato ad ingombro riducibile per il trasporto dipersone
GR880100196A (el) Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους
FR2636089B1 (fr) Construction legere, demontable, du genre gloriette, kiosque, edicules divers
IT1215022B (it) Lettino o recinto per bambini ad ingombro riducibile
ITMI922069A0 (it) Composti dotati di caratteristiche fotocromatiche in presenza di ossigeno e metodi per la loro preparazione